Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Windtree Therapeutics Inc (ID) WINT

Healthcare Biotechnology
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4... see more

Current News ()

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

GlobeNewswire December 23, 2025

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

GlobeNewswire December 3, 2025

Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee

GlobeNewswire November 17, 2025

Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate

GlobeNewswire November 14, 2025

Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company

GlobeNewswire November 13, 2025

Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at the Special Stockholder Meeting

GlobeNewswire September 2, 2025

Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025

GlobeNewswire August 11, 2025

Windtree Announces Istaroxime Phase 2 Interim Analysis in SCAI Stage C Cardiogenic Shock Patients

GlobeNewswire August 5, 2025

Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

GlobeNewswire July 29, 2025
View More News ››

Opinion & Analysis ()

No current opinion is available.
View More Opinion ››

Bullboard Posts ()

WINT....doing that "WINT" Thang ; )

up again during pre-market open Will it retrace again during Reg Hours trading? Time will tell....$1.20
Iseneschal - July 18, 2025

Buy buddy buy because it's taking off this morning.

Otherwise FOMO for you guys out there
coolfooldumbguy - July 17, 2025

WINT....1st scalp of the a.m

Out at $1.30
Iseneschal - July 17, 2025

WINT...U know they will be doing a financing

It will be announced soon....so it could ramp up higher You have been warned....currently at $1.16
Iseneschal - July 17, 2025

RE:WINT... Two S1 Ammendments filed recently

No announcement yet? Wait for it because it's going to happen ; ) Share price now trading at $0.8265 on 72 million shares...What a...
Iseneschal - July 14, 2025

Buy buddy buy.

Otherwise FOMO for you fellas out there today
coolfooldumbguy - July 14, 2025
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »

Podcasts